• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

摩尔齿轮:一个基于 Java 的进化从头分子设计平台。

MoleGear: A Java-Based Platform for Evolutionary De Novo Molecular Design.

机构信息

Department of Chemical Engineering, Norwegian University of Science and Technology, N-7491 Trondheim, Norway.

出版信息

Molecules. 2019 Apr 11;24(7):1444. doi: 10.3390/molecules24071444.

DOI:10.3390/molecules24071444
PMID:30979097
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6479339/
Abstract

A Java-based platform, MoleGear, is developed for de novo molecular design based on the chemistry development kit (CDK) and other Java packages. MoleGear uses evolutionary algorithm (EA) to explore chemical space, and a suite of fragment-based operators of growing, crossover, and mutation for assembling novel molecules that can be scored by prediction of binding free energy or a weighted-sum multi-objective fitness function. The EA can be conducted in parallel over multiple nodes to support large-scale molecular optimizations. Some complementary utilities such as fragment library design, chemical space analysis, and graphical user interface are also integrated into MoleGear. The candidate molecules as inhibitors for the human immunodeficiency virus 1 (HIV-1) protease were designed by MoleGear, which validates the potential capability for de novo molecular design.

摘要

一个基于 Java 的平台 MoleGear 是为从头分子设计开发的,它基于化学开发工具包(CDK)和其他 Java 包。 MoleGear 使用进化算法(EA)来探索化学空间,并使用一系列基于片段的生长、交叉和突变算子来组装新的分子,这些分子可以通过预测结合自由能或加权和多目标适应度函数来评分。EA 可以在多个节点上并行进行,以支持大规模的分子优化。MoleGear 还集成了一些补充工具,如片段库设计、化学空间分析和图形用户界面。通过 MoleGear 设计了人免疫缺陷病毒 1(HIV-1)蛋白酶抑制剂的候选分子,验证了从头分子设计的潜在能力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/1609c0fe904c/molecules-24-01444-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/4af427b6e784/molecules-24-01444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/40e984f6a359/molecules-24-01444-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/1d43738fa9c7/molecules-24-01444-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/324f5874033f/molecules-24-01444-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/9114cd3c4417/molecules-24-01444-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/1a3180eeb7e3/molecules-24-01444-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/afd4cd0d3805/molecules-24-01444-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/ade549b8fd62/molecules-24-01444-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/f98c384c46c2/molecules-24-01444-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/13a474a2bb07/molecules-24-01444-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/fdd910e4f40f/molecules-24-01444-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/da13fff97160/molecules-24-01444-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/1609c0fe904c/molecules-24-01444-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/4af427b6e784/molecules-24-01444-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/40e984f6a359/molecules-24-01444-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/1d43738fa9c7/molecules-24-01444-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/324f5874033f/molecules-24-01444-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/9114cd3c4417/molecules-24-01444-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/1a3180eeb7e3/molecules-24-01444-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/afd4cd0d3805/molecules-24-01444-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/ade549b8fd62/molecules-24-01444-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/f98c384c46c2/molecules-24-01444-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/13a474a2bb07/molecules-24-01444-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/fdd910e4f40f/molecules-24-01444-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/da13fff97160/molecules-24-01444-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0317/6479339/1609c0fe904c/molecules-24-01444-g013.jpg

相似文献

1
MoleGear: A Java-Based Platform for Evolutionary De Novo Molecular Design.摩尔齿轮:一个基于 Java 的进化从头分子设计平台。
Molecules. 2019 Apr 11;24(7):1444. doi: 10.3390/molecules24071444.
2
Flux (2): comparison of molecular mutation and crossover operators for ligand-based de novo design.通量(2):基于配体的从头设计中分子突变和交叉算子的比较。
J Chem Inf Model. 2007 Mar-Apr;47(2):656-67. doi: 10.1021/ci6005307. Epub 2007 Feb 23.
3
Multiple Target Drug Design Using LigBuilder 3.使用LigBuilder 3进行多靶点药物设计。
Methods Mol Biol. 2021;2266:279-298. doi: 10.1007/978-1-0716-1209-5_16.
4
EvoMD: an algorithm for evolutionary molecular design.EvoMD:一种进化分子设计算法。
IEEE/ACM Trans Comput Biol Bioinform. 2011 Jul-Aug;8(4):987-1003. doi: 10.1109/TCBB.2010.100.
5
De novo design of drug-like molecules by a fragment-based molecular evolutionary approach.基于片段的分子进化方法从头设计类药性分子。
J Chem Inf Model. 2014 Jan 27;54(1):49-56. doi: 10.1021/ci400418c. Epub 2014 Jan 13.
6
LEADD: Lamarckian evolutionary algorithm for de novo drug design.LEADD:用于从头药物设计的拉马克进化算法。
J Cheminform. 2022 Jan 15;14(1):3. doi: 10.1186/s13321-022-00582-y.
7
Multi-objective Genetic Algorithm for De Novo Drug Design (MoGADdrug).多目标遗传算法的从头药物设计(MoGADdrug)。
Curr Comput Aided Drug Des. 2021;17(3):445-457. doi: 10.2174/1573409916666200620194143.
8
In silico fragment-based drug discovery: setup and validation of a fragment-to-lead computational protocol using S4MPLE.基于片段的计算机药物发现:使用 S4MPLE 建立和验证片段至先导物的计算方案。
J Chem Inf Model. 2013 Apr 22;53(4):836-51. doi: 10.1021/ci4000163. Epub 2013 Apr 11.
9
A hierarchical model of HIV-1 protease drug resistance.一种HIV-1蛋白酶耐药性的层次模型。
Appl Bioinformatics. 2002;1(1):3-12.
10
A genetic algorithm for the automated generation of small organic molecules: drug design using an evolutionary algorithm.一种用于自动生成小分子有机化合物的遗传算法:使用进化算法进行药物设计。
J Comput Aided Mol Des. 2000 Jul;14(5):449-66. doi: 10.1023/a:1008108423895.

引用本文的文献

1
Crossover operators for molecular graphs with an application to virtual drug screening.用于分子图的交叉算子及其在虚拟药物筛选中的应用。
J Cheminform. 2025 Jun 17;17(1):97. doi: 10.1186/s13321-025-00958-w.
2
The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges.利用人工智能到深度学习进行药物发现的不断变化的情况:最新进展、成功案例、合作与挑战。
Mol Ther Nucleic Acids. 2024 Aug 8;35(3):102295. doi: 10.1016/j.omtn.2024.102295. eCollection 2024 Sep 10.
3
Quantum-assisted fragment-based automated structure generator (QFASG) for small molecule design: an study.

本文引用的文献

1
MoDoop: An Automated Computational Approach for COSMO-RS Prediction of Biopolymer Solubilities in Ionic Liquids.MoDoop:一种用于COSMO-RS预测离子液体中生物聚合物溶解度的自动化计算方法。
ACS Omega. 2019 Jan 30;4(1):2337-2343. doi: 10.1021/acsomega.8b03255. eCollection 2019 Jan 31.
2
Combining Ensemble Learning with a Fragment-Based Topological Approach To Generate New Molecular Diversity in Drug Discovery: In Silico Design of Hsp90 Inhibitors.将集成学习与基于片段的拓扑方法相结合以在药物发现中产生新的分子多样性:热休克蛋白90抑制剂的计算机辅助设计
ACS Omega. 2018 Nov 30;3(11):14704-14716. doi: 10.1021/acsomega.8b02419. Epub 2018 Nov 2.
3
用于小分子设计的量子辅助基于片段的自动结构生成器(QFASG):一项研究。
Front Chem. 2024 Apr 3;12:1382512. doi: 10.3389/fchem.2024.1382512. eCollection 2024.
4
Recent Advances in Automated Structure-Based De Novo Drug Design.基于结构的从头药物设计的最新进展。
J Chem Inf Model. 2024 Mar 25;64(6):1794-1805. doi: 10.1021/acs.jcim.4c00247. Epub 2024 Mar 14.
5
Development and application of fragment-based de novo inhibitor design approaches against Plasmodium falciparum GST.针对恶性疟原虫 GST 的从头抑制剂设计方法的开发与应用
J Mol Model. 2023 Aug 16;29(9):281. doi: 10.1007/s00894-023-05650-0.
6
GenUI: interactive and extensible open source software platform for de novo molecular generation and cheminformatics.GenUI:用于从头分子生成和化学信息学的交互式可扩展开源软件平台。
J Cheminform. 2021 Sep 25;13(1):73. doi: 10.1186/s13321-021-00550-y.
7
AutoGrow4: an open-source genetic algorithm for de novo drug design and lead optimization.AutoGrow4:一种用于从头药物设计和先导化合物优化的开源遗传算法。
J Cheminform. 2020 Apr 17;12(1):25. doi: 10.1186/s13321-020-00429-4.
8
Autonomous molecule generation using reinforcement learning and docking to develop potential novel inhibitors.利用强化学习和对接技术进行自主分子生成以开发潜在的新型抑制剂。
Sci Rep. 2020 Dec 16;10(1):22104. doi: 10.1038/s41598-020-78537-2.
Deep reinforcement learning for de novo drug design.
基于深度强化学习的从头药物设计。
Sci Adv. 2018 Jul 25;4(7):eaap7885. doi: 10.1126/sciadv.aap7885. eCollection 2018 Jul.
4
Docking-based inverse virtual screening: methods, applications, and challenges.基于对接的反向虚拟筛选:方法、应用及挑战
Biophys Rep. 2018;4(1):1-16. doi: 10.1007/s41048-017-0045-8. Epub 2018 Feb 1.
5
Docking-based virtual screening of Brazilian natural compounds using the OOMT as the pharmacological target database.以OOMT作为药理靶点数据库,基于对接的巴西天然化合物虚拟筛选。
J Mol Model. 2017 Apr;23(4):111. doi: 10.1007/s00894-017-3253-8. Epub 2017 Mar 11.
6
Neural-Network-Biased Genetic Algorithms for Materials Design: Evolutionary Algorithms That Learn.用于材料设计的神经网络偏置遗传算法:可学习的进化算法
ACS Comb Sci. 2017 Feb 13;19(2):96-107. doi: 10.1021/acscombsci.6b00136. Epub 2017 Jan 9.
7
Chemical-Space-Based de Novo Design Method To Generate Drug-Like Molecules.基于化学空间的从头设计方法以生成类药物分子。
J Chem Inf Model. 2016 Oct 24;56(10):1885-1893. doi: 10.1021/acs.jcim.6b00038. Epub 2016 Sep 30.
8
Comparative modeling and benchmarking data sets for human histone deacetylases and sirtuin families.人类组蛋白去乙酰化酶和沉默调节蛋白家族的比较建模与基准数据集。
J Chem Inf Model. 2015 Feb 23;55(2):374-88. doi: 10.1021/ci5005515. Epub 2015 Feb 9.
9
New insights into the in silico prediction of HIV protease resistance to nelfinavir.深入了解 HIV 蛋白酶对奈非那韦耐药性的计算机预测。
PLoS One. 2014 Jan 31;9(1):e87520. doi: 10.1371/journal.pone.0087520. eCollection 2014.
10
De novo design of drug-like molecules by a fragment-based molecular evolutionary approach.基于片段的分子进化方法从头设计类药性分子。
J Chem Inf Model. 2014 Jan 27;54(1):49-56. doi: 10.1021/ci400418c. Epub 2014 Jan 13.